Roche Receives FDA Clearance for Point-of-Care Bordetella Test
Roche announced that its point-of-care test for detecting Bordetella infections, including whooping cough (pertussis), has received US Food…
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
F. Hoffmann-La Roche Ltd The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth](https://www.europesays.com/ch/wp-content/uploads/2026/02/84b0110bbf60eb8397db0461bc3549c4-380x220.png)
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
F. Hoffmann-La Roche Ltd The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to…
Roche gets FDA clearance for 15-minute pertussis POC test
Roche (OTCQX:RHHBY) announced U.S. FDA 510(k) clearance with a CLIA waiver and CE…